| Name | 1,3-dichloro-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]benzene |
|---|---|
| Synonyms |
1,3-Dichloro-5-{(E)-2-[4-(trifluoromethyl)phenyl]vinyl}benzene
1,3-dichloro-5-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}benzene Benzene, 1,3-dichloro-5-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]- |
| Description | CAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM). |
|---|---|
| Related Catalog | |
| Target |
Ki: 0.2 nM (AhR)[1] |
| In Vitro | CAY 10465 (Compound 4i) is a selective and high-affinity AhR receptor agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM)[1]. CAY 10465 (0.01 nM-100 μM) reduces apolipoprotein A-I (apo A-I) levels in HepG2 cells, and inhibits the synthesis of the protein[2]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 361.2±42.0 °C at 760 mmHg |
| Molecular Formula | C15H9Cl2F3 |
| Molecular Weight | 317.133 |
| Flash Point | 201.8±21.3 °C |
| Exact Mass | 316.003326 |
| LogP | 7.01 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.597 |
| Storage condition | 2-8℃ |